新型合成单环β-内酰胺类抗生素卡芦莫南的药代动力学及组织穿透性
Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.
作者信息
McNulty C A, Garden G M, Ashby J, Wise R
出版信息
Antimicrob Agents Chemother. 1985 Sep;28(3):425-7. doi: 10.1128/AAC.28.3.425.
Abstract
The pharmacokinetics of the monobactam carumonam (Ro 17-2301) as derived from serial measurement of the concentrations of this agent in serum, blister fluid, and urine were studied in six male volunteers subsequent to intravenous infusion of a single 2-g dose. Drug levels in serum in excess of 75 micrograms/ml were achieved 0.5 h after the end of infusion, declining to 2.9 micrograms/ml at 8 h. The mean serum and blister fluid elimination half-lives were 1.68 and 1.7 h, respectively. The urinary recovery of the drug by 24 h was 80.6% (range, 68.3 to 91.1%). Carumonam penetrated blister fluid well, the mean percentage penetration (as measured by the ratio of areas under curves) being 101.6%.
摘要
在6名男性志愿者静脉输注单次2克剂量后，通过连续测定血清、水疱液和尿液中单环β-内酰胺类药物卡芦莫南（Ro 17 - 2301）的浓度，研究了其药代动力学。输注结束后0.5小时血清药物水平超过75微克/毫升，8小时时降至2.9微克/毫升。血清和水疱液的平均消除半衰期分别为1.68小时和1.7小时。24小时药物经尿液回收量为80.6%（范围为68.3%至91.1%）。卡芦莫南能很好地渗透入水疱液，平均渗透百分比（通过曲线下面积比测量）为101.6%。
相似文献
1
Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.新型合成单环β-内酰胺类抗生素卡芦莫南的药代动力学及组织穿透性
Antimicrob Agents Chemother. 1985 Sep;28(3):425-7. doi: 10.1128/AAC.28.3.425.
2
Pharmacokinetics and tissue penetration of azthreonam.氨曲南的药代动力学及组织穿透性。
Antimicrob Agents Chemother. 1982 Dec;22(6):969-71. doi: 10.1128/AAC.22.6.969.
3
Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration.替考拉宁及其药代动力学、水疱和腹膜液渗透情况。
J Hosp Infect. 1986 Mar;7 Suppl A:47-55. doi: 10.1016/0195-6701(86)90007-1.
4
Pharmacokinetics of carumonam after single and multiple 1- and 2-g dosage regimens.卡芦莫南单次及多次给予1克和2克剂量方案后的药代动力学。
Antimicrob Agents Chemother. 1988 Mar;32(3):354-7. doi: 10.1128/AAC.32.3.354.
5
Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs.新型N-磺化单环β-内酰胺类药物卡芦莫南（AMA-1080/Ro 17-2301）在大鼠和犬体内的处置情况。
Antimicrob Agents Chemother. 1986 Jun;29(6):1017-24. doi: 10.1128/AAC.29.6.1017.
6
Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.卡芦莫南和氨曲南在小鼠、大鼠、家兔、犬及食蟹猴体内的比较药代动力学。
Antimicrob Agents Chemother. 1986 Jan;29(1):127-34. doi: 10.1128/AAC.29.1.127.
7
Pharmacokinetics of carumonam in patients with renal insufficiency.卡芦莫南在肾功能不全患者中的药代动力学。
Antimicrob Agents Chemother. 1986 Jan;29(1):116-21. doi: 10.1128/AAC.29.1.116.
8
Comparison of ceftazidime and cefamandole pharmacokinetics and blister fluid concentrations.头孢他啶与头孢孟多的药代动力学及水疱液浓度比较。
Antimicrob Agents Chemother. 1981 Sep;20(3):356-8. doi: 10.1128/AAC.20.3.356.
9
The pharmacokinetics and tissue penetration of teicoplanin.替考拉宁的药代动力学和组织穿透性。
J Antimicrob Chemother. 1985 Dec;16(6):743-9. doi: 10.1093/jac/16.6.743.
10
Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.单环β-内酰胺类药物Ro 17-2301（AMA-1080）在人体中的单剂量药代动力学。
Antimicrob Agents Chemother. 1984 Dec;26(6):898-902. doi: 10.1128/AAC.26.6.898.
引用本文的文献
1
Conjugation of Aztreonam, a Synthetic Monocyclic β-Lactam Antibiotic, to a Siderophore Mimetic Significantly Expands Activity Against Gram-Negative Bacteria.阿佐米星（一种合成单环β-内酰胺抗生素）与铁载体模拟物的缀合显著增强了对革兰氏阴性菌的活性。
ACS Infect Dis. 2021 Nov 12;7(11):2979-2986. doi: 10.1021/acsinfecdis.1c00458. Epub 2021 Oct 20.
2
Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.金属β-内酰胺酶在多药耐药时代：从结构和机制到进化、传播和抑制剂设计。
Chem Rev. 2021 Jul 14;121(13):7957-8094. doi: 10.1021/acs.chemrev.1c00138. Epub 2021 Jun 15.
3
Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis.四十年来囊性纤维化患者β-内酰胺类抗生素的药代动力学研究
Clin Pharmacokinet. 2019 Feb;58(2):143-156. doi: 10.1007/s40262-018-0678-x.
4
Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs.新型N-磺化单环β-内酰胺类药物卡芦莫南（AMA-1080/Ro 17-2301）在大鼠和犬体内的处置情况。
Antimicrob Agents Chemother. 1986 Jun;29(6):1017-24. doi: 10.1128/AAC.29.6.1017.
5
Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods.卡芦莫南药敏试验：30微克纸片试验的解释标准及纸片扩散法和肉汤微量稀释法的质量控制指南。
J Clin Microbiol. 1987 Nov;25(11):2243-6. doi: 10.1128/jcm.25.11.2243-2246.1987.
6
Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.卡芦莫南（Ro 17 - 2301；AMA - 1080）与庆大霉素治疗复杂性尿路感染的比较。
Antimicrob Agents Chemother. 1988 Apr;32(4):473-6. doi: 10.1128/AAC.32.4.473.
7
Pharmacokinetics of carumonam after single and multiple 1- and 2-g dosage regimens.卡芦莫南单次及多次给予1克和2克剂量方案后的药代动力学。
Antimicrob Agents Chemother. 1988 Mar;32(3):354-7. doi: 10.1128/AAC.32.3.354.
8
Antibacterial activity of Ro 17-2301 and other antimicrobial agents against cefotaxime-resistant aerobic gram-negative bacilli.Ro 17-2301及其他抗菌剂对耐头孢噻肟需氧革兰氏阴性杆菌的抗菌活性。
Antimicrob Agents Chemother. 1986 Jan;29(1):155-7. doi: 10.1128/AAC.29.1.155.
9
Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis.卡芦莫南（AMA - 1080）在肾功能受损患者及血液透析患者中的药代动力学。
Antimicrob Agents Chemother. 1991 Jun;35(6):1048-52. doi: 10.1128/AAC.35.6.1048.
本文引用的文献
1
The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.蛋白质结合对六种β-内酰胺类抗生素组织液水平的影响。
J Infect Dis. 1980 Jul;142(1):77-82. doi: 10.1093/infdis/142.1.77.
2
Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjects.
J Antimicrob Chemother. 1981 Dec;8 Suppl E:131-40. doi: 10.1093/jac/8.suppl_e.131.
3
Pharmacokinetics and tissue penetration of azthreonam.氨曲南的药代动力学及组织穿透性。
Antimicrob Agents Chemother. 1982 Dec;22(6):969-71. doi: 10.1128/AAC.22.6.969.
4
Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.单环β-内酰胺类药物Ro 17-2301（AMA-1080）在人体中的单剂量药代动力学。
Antimicrob Agents Chemother. 1984 Dec;26(6):898-902. doi: 10.1128/AAC.26.6.898.
5
The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents.新型单环β-内酰胺类抗生素Ro 17-2301与其他抗菌药物的体外活性比较。
J Antimicrob Chemother. 1985 Feb;15(2):193-200. doi: 10.1093/jac/15.2.193.
Zotero 插件